Peptides for Weight Loss in 2026

The most-studied peptides for weight loss are the GLP-1 medicines semaglutide and tirzepatide, and yes, both are peptides. Taking charge of your metabolic health is a smart move, and pru is built to make that informed choice an accessible one.

GLP-1 medicines like semaglutide and tirzepatide are peptides

A peptide is a short chain of amino acids that acts as a signal in your body. GLP-1 medicines are exactly that. Semaglutide and tirzepatide are engineered peptides that mimic gut hormones your body already makes, so when people search for the best peptides for weight loss, they are usually searching for GLP-1s without knowing it.

GLP-1 stands for glucagon-like peptide-1. This hormone helps signal fullness and slow how fast your stomach empties. Semaglutide targets the GLP-1 receptor. Tirzepatide targets two receptors, GLP-1 and GIP, which is why it is sometimes called a dual agonist. Because tirzepatide engages both receptors, it tends to have a higher weight-loss ceiling than semaglutide in studies of the branded drugs, though those trial results describe the branded drugs, not a promise about a compounded product. Both are given as a once-weekly injection under a prescriber's care.

Because they are peptides, GLP-1s belong to the same family as the other therapies pru works with. That focus is the point. You are not piecing together vendors. You can compare options like semaglutide and tirzepatide side by side in one place built for peptides.

The peptides people ask about for weight loss, and where each stands

Below are the peptides people most often ask about for weight and metabolism, covered together so you can see the full field, not only what is on the shelf today. A few of these pru does not offer yet.

That is deliberate: pru adds a peptide only once there is a safe, prescribed pathway with an FDA-registered 503A pharmacy behind it. MOTS-c is one of the peptides under review at the FDA's July 2026 Pharmacy Compounding Advisory Committee (PCAC) meeting, which will help shape whether and how it can be compounded.

Retatrutide is an engineered peptide that engages three receptors at once, GLP-1, GIP, and glucagon, which is why it is called a triple agonist. It is studied for weight loss and broader metabolic health.

Cagrilintide is a long-acting amylin analog, a peptide that mimics amylin, a hormone your body releases alongside insulin. It is studied for appetite and fullness, often paired with a GLP-1 in weight-management research.

AOD-9604 is a fragment of human growth hormone (amino acids 176-191), not a GLP-1. It is studied for fat metabolism and is thought to encourage the body to break down fat (lipolysis) without changing appetite.

MOTS-c is a mitochondrial-derived peptide, not a GLP-1, studied as an exercise mimetic. It is studied for metabolism and how cells produce and use energy, with research interest in fat use and endurance.

Tesamorelin is a growth-hormone-releasing peptide studied for reducing visceral fat, the deep abdominal fat around the organs. It prompts the body's own growth-hormone signaling rather than replacing it.

The best-studied peptides for weight and metabolism, at a glance

Three peptides carry the most research and the most real-world use for weight and metabolism: semaglutide, tirzepatide, and the non-GLP-1 option AOD-9604. The table below compares them on what they are and how you get them. You choose the one that fits your goal, guided by pru's content, and a physician confirms whether it is a clinical fit for you.

Two non-GLP-1 peptides round out the options. AOD-9604 is a fragment of human growth hormone studied for fat metabolism, thought to encourage the body to break down fat (lipolysis) without changing appetite. MOTs-C is a mitochondrial-derived peptide studied as an exercise mimetic, thought to support how cells produce and use energy, with research interest in metabolism and endurance. Both are on pru's roadmap as regulations allow. To weigh the two GLP-1s against each other, start with semaglutide vs tirzepatide.

Branded GLP-1 drugs and compounded peptides are different products

Branded GLP-1 drugs and compounded peptide medicine are separate things, and it matters that you know the difference. Ozempic and Wegovy are FDA-approved semaglutide products made by Novo Nordisk. Mounjaro and Zepbound are FDA-approved tirzepatide products made by Eli Lilly. Those are finished, brand-name drugs.

Compounded semaglutide and compounded tirzepatide are different. They are individualized medications that a licensed physician prescribes for a specific patient and a licensed pharmacy prepares by hand. They are pharmacy-grade, not FDA-approved, and they are their own distinct medicine. Compare them to the branded drugs on access, cost, and oversight, not on being the same product.

Both are well-studied options with different ceilings and track records, and the route is what pru focuses on. You can go deeper on each in compounded semaglutide and compounded tirzepatide.

The real risk is a grey-market vial, not the peptide itself

The genuine danger in this space is not the peptide. It is buying a grey-market "research-grade" vial with no prescriber, no licensed pharmacy, and no accountability. That is where things go wrong.

Vials sold online labeled "for research use only" or "not for human consumption" skip every safeguard that makes medicine safe. There is no physician deciding it is right for you, no state-licensed pharmacy verifying quality, and no dosing oversight. The FDA has logged hundreds of adverse-event reports tied to compounded GLP-1s used without proper guidance, many of them dosing errors where people drew the wrong amount from a multi-dose vial. Getting your dose from a licensed prescriber and pharmacy is what prevents that.

How you take a GLP-1 peptide and what to expect

A GLP-1 peptide is a small once-weekly injection you give yourself under the skin, usually in the abdomen, thigh, or upper arm. The needle is short and fine, and most people find it quick and nearly painless once they have done it a few times. You do not take it every day, and you do not swallow a pill. It is one shot, one day a week, on a schedule your prescriber sets.

You start low and build up slowly. This is called titration, and it is the standard way GLP-1 medicine is used. Your prescriber begins you at a small dose and steps it up over weeks. Going slow is what eases the most common side effects, which are mostly digestive: nausea, a feeling of fullness, sometimes constipation or loose stools.

These tend to be strongest right after a dose increase and to settle as your body adjusts. If they are hard to tolerate, a prescriber can slow the pace or hold you at a dose rather than pushing higher.

Protecting muscle while you lose fat

When you lose weight quickly, some of what you lose can be lean muscle, not just fat. The goal for most people is to keep the muscle and lose the fat, which is why what you do alongside a GLP-1 matters as much as the medicine. Two habits carry most of the weight here: eating enough protein and doing regular resistance training. Those two things give your body a reason to hold onto muscle while the fat comes off.

There is also a peptide angle. A growth-hormone peptide like sermorelin can be paired with a GLP-1 to help support lean muscle during weight loss. Sermorelin prompts your body's own growth-hormone signaling, and clinicians sometimes use it in a body-recomposition pairing, meaning losing fat while protecting muscle, alongside protein and training rather than in place of them. Whether it fits you is a decision your prescriber makes.

What the research actually shows, peptide by peptide

It helps to know where the evidence comes from. The strong weight-loss numbers you have seen belong to the branded, FDA-approved drugs and the trials that studied them.

• Semaglutide: In Novo Nordisk's STEP trials of Wegovy, participants lost about 15% of body weight on average over 68 weeks. Those are the branded drug's trial results, not a promise about a compounded product.
• Tirzepatide: In Eli Lilly's SURMOUNT trials of Zepbound, participants lost about 20% of body weight on average at the highest dose. Those are the branded drug's trial results, not a promise about a compounded product.
• AOD-9604: A fragment of human growth hormone (amino acids 176-191), not a GLP-1. It is studied for fat metabolism and thought to encourage the body to break down fat (lipolysis) without the blood-sugar effects of full growth hormone. It is on pru's roadmap, pending regulatory review.
• MOTs-C: A mitochondrial-derived peptide, not a GLP-1, studied as an exercise mimetic. It is thought to support how cells produce and use energy, with research interest in metabolism, insulin sensitivity, and endurance. It is on pru's roadmap as regulations allow.

Read those numbers for what they are: outcomes from large trials of the finished branded drugs, given as background so you understand the science. What a compounded, individualized medicine does for one specific patient is a clinical matter between that person and their prescriber.

How pru handles peptides for weight loss

pru makes peptides simple by pairing a licensed physician with a licensed 503A pharmacy and pricing the medicine at cost. You are not buying a mystery vial. You are getting individualized, prescribed, pharmacy-grade medicine through a clear path.

Here is what makes the model different. A flat membership of about $50 a month, billed annually, funds the platform. Every peptide is then priced at cost and itemized, so you see the pharmacy fill, supplies, shipping, and consult broken out with no markup on the medicine itself. That is the transparency other options rarely give you. You can see exactly how it works on the pricing page.

If a GLP-1 is right for you, a physician can prescribe semaglutide or tirzepatide, and the full set of options lives in weight loss and metabolism. One membership, easy access, complete support, and transparent at-cost pricing. That is how pru does peptides for weight loss. If you are already thinking about your metabolic health, that instinct is worth acting on, and pru exists to make the smart path the accessible one, so take the next step when you are ready.

Related reading

• Best peptides by goal
• Compounded semaglutide, explained
• Semaglutide dosage and titration
• Semaglutide side effects and results
• browse the full catalog

Common questions